Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Oct 14 - Oct 19
A Certificate of Analysis for the current lot is available on request, before you commit to an order
In Phase 2b with human patients, the oral route was not confirmed
Protective pads and adjustments in daily habits can reduce the risk of another episode
Last reviewed: May 28, 2026 Last updated: May 28, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
The publication also noted Hims & Hers reached a $7.6 billion market cap and acquired a dedicated compounding pharmacy in September 2024
US$ 20.86
US$ 28.07
US$ 29.76
US$ 21.65
US$ 29.02
